During which phase of the research process do MSLs typically begin surveillance of a specific therapeutic area or compound?

During which phase of the research process do MSLs typically begin surveillance of a specific therapeutic area or compound?

• A. Phase I
• B. Phase II
• C. Phase III
• D. Phase IV

Answer: (B)

Surveillance by MSLs starts when there is enough clinical data to support meaningful scientific dialogue with healthcare professionals. That point commonly occurs in Phase II, where early efficacy signals and a clearer safety profile begin to emerge in a defined patient population. With this information, MSLs can monitor trial results, track literature, identify relevant disease experts, and start building relationships to discuss the therapy in a knowledgeable way. In Phase I, data are typically too preliminary to support broad external scientific engagement. In Phase III, the results are often pivotal and guiding treatment decisions, but by then the groundwork for external scientific dialogue has typically already begun in Phase II. Phase IV continues ongoing surveillance after a product is marketed, but the initial shift into systematic surveillance of the area or compound is usually during Phase II.

Surveillance by MSLs starts when there is enough clinical data to support meaningful scientific dialogue with healthcare professionals. That point commonly occurs in Phase II, where early efficacy signals and a clearer safety profile begin to emerge in a defined patient population. With this information, MSLs can monitor trial results, track literature, identify relevant disease experts, and start building relationships to discuss the therapy in a knowledgeable way.

In Phase I, data are typically too preliminary to support broad external scientific engagement. In Phase III, the results are often pivotal and guiding treatment decisions, but by then the groundwork for external scientific dialogue has typically already begun in Phase II. Phase IV continues ongoing surveillance after a product is marketed, but the initial shift into systematic surveillance of the area or compound is usually during Phase II.